Budesonide Oral Product

Known as: budesonide oral, oral budesonide 
 

Topic mentions per year

Topic mentions per year

1995-2016
02419952016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND & AIMS No treatment has been approved by the U.S. Food and Drug Administration for eosinophilic esophagitis (EoE). We… (More)
Is this relevant?
2015
2015
WHAT IS KNOWN AND OBJECTIVE Budesonide, an oral glucocorticoid indicated for the treatment of Crohn's disease, rarely interferes… (More)
Is this relevant?
2013
2013
BACKGROUND AND AIMS Current treatments for Japanese patients with active Crohn's disease have not proved optimal, and new… (More)
Is this relevant?
2012
2012
BACKGROUND   Protein-losing enteropathy is associated with Fontan palliation for single-ventricle physiology and has been… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND & AIMS Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus characterized by dense tissue… (More)
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2009
2009
OBJECTIVE To evaluate the efficacy and safety of long-term budesonide therapy for the maintenance of clinical remission in… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2009
2009
Grapefruit juice (GFJ) inhibits CYP3A activity in the gut wall, thereby decreasing first-pass metabolism of CYP3A substrates. In… (More)
Is this relevant?
2007
2007
Recent case reports suggest that addition of high-dose metronidazole might be associated with elevated plasma concentrations of… (More)
Is this relevant?
2000
2000
OBJECTIVE:This study was designed to evaluate the safety and estimate the efficacy of oral budesonide in patients with primary… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
1999
1999
AIM To assess the systemic effect of oral budesonide, given as Entocort controlled ileal release capsules, over a dose range of 3… (More)
Is this relevant?